Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.
Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.
The grassroots hemp and CBD brand ‘Hempen Organic’ looking to fundraise for greater exposure has had its crowdfunding campaign pulled due to CBD regulatory risks.
The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.
UK-based startup Goodrays is seeking to bring the benefits of CBD to multiple consumer occasions throughout the day with its wide range of oils, gummies, and drinks.
A broad-spectrum medicinal cannabis oil is effective in significantly improving sleep quality and duration, midnight melatonin levels, as well as quality of life and mood within two weeks, in adults with insomnia, according to new research.
She may be a serial entrepreneur, humanitarian, health coach and the founder of a hemp company, but perhaps what makes Inesa Ponomariovaite stand out the most is her incredible story of survival.
Najla Guthrie, president and CEO, KGK Science Inc. has been hailed as a global leader and sought-after spokesperson in the nutraceutical trade. She is also a lobbyist for the advancement of policy changes in the supplement and cannabis industries.
Functional beverages are a thriving category – but what exactly are consumers looking for in their drinks? From cannabis beverages to ‘think drinks’, hear from a panel of experts as this free-to-attend webinar explores the potential of the category.
Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?
Between Covid-19, supply chain issues and inflation, life is taking a serious toll on mental health. But more and more people are looking for ways to address mental health without a prescription.
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
As the stigma surrounding cannabinoids fades, hemp-derived supplements are gaining traction as popular applications for pain management. New research from the University of Arizona Health Sciences in the Comprehensive Pain and Addiction Center have found...
While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...
FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.
One of the UK’s biggest white label manufacturers, purely dedicated to CBD, believes the publication of the Food Standard’s Agency list will leave the market with a “pool of very vanilla products” and says it’s frustrating after the industry has moved...
A new commission has been set up by The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI) and First November Group to review the legal cannabis industry in the UK.
Researchers found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, preventing a critical step in the process the virus uses to infect people.
Consumers suffering from chronic diseases or cancer could be vulnerable to the empty promises and misleading health claims, which is why Dr Janet Schloss, the latest guest on our NutraChampion podcast, has made it her mission to drive an evidence-based...
NutraIngredients-USA's free webinar on May 14 will explore the science of hemp-derived cannabinoids (including CBD) and terpenes - there's still time to register.
An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
Defendants in a recent spate of lawsuits alleging discrepancies between the amount of CBD advertised on pack and the amount contained in the products, have hit back in motions to dismiss, with one arguing that such cases should be stayed until the FDA...
Microbial detection company Hygiena says cannabis is rapidly expanding as an ingredient in foods such as baked goods, oils, drinks and butter, but due to its popularity companies run a higher risk of producing contaminated and unsafe products.
The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
Beverages under the Zola and Caliva brands featuring hemp-derived CBD will start to hit the US market around August or September, says Zola founder Chris Cuvelier, who recently took the helm at a new beverage division at Caliva after the San Jose-based...
Beer and wine giant Constellation Brands made headlines this year by announcing its investment of $4bn USD in Canadian cannabis company Canopy Growth. Rob Sands, CEO of Constellation Brands, says that the cannabis space is opening up much more rapidly...
Neptune Technologies and Bioressources has concluded a partnership to research krill oil combinations with CBD for wellness products as well as possible medical cannabis applications.
Australian nutraceutical cannabinoid manufacturer Creso Pharma has signed a deal to market its flagship hemp-based product in Switzerland and Lichtenstein, shortly after announcing its market entry into China.
Cannabinoids can be safely used as a supplementary treatment for elderly people with Parkinson’s disease with evidence showing they help reduce tremors, rigidity and pain, a new review reports.
The European Industrial Hemp Association (EIHA) says there is an “urgent need for proper legislation” in a position paper asking for Europe to recognise cannabidiol (CBD) and hemp as safe ingredients in food and cosmetics – not just medicines.
Australian company Medlab Clinical Limited is preparing to start Australia’s first clinical trial using cannabis for oncology patients suffering intractable pain.
An Australian hemp pioneer has reacted with caution to a government proposal to allow the cultivation of cannabis in Australia for medical and scientific purposes.
Guest column, chief executive of Elixinol and Hemp Foods Australia
Once forgotten, cannabinoids and their medicinal benefits have recently been thrust back into the spotlight, in particular for their abilities to relieve often otherwise untreatable pain.
Telling a story is important for any brand – even more so when trying to market hemp juice and overcome pre-conceptions about cannabis, according to Sana Hemp Juice.
Australian regulators are considering allowing non-psychoactive versions of fatty acid and nutrient-rich hemp into the food supply and have opened a public consultation on the matter.
Hemp advocates are angered by Governor Schwarzenegger's veto of an
industrial hemp bill that would have allowed local farmers to
legally produce and supply the nutritious seed.
US researchers are developing a marijuana-derived synthetic
compound to relieve pain and inflammation without the mood-altering
side-effects associated with other marijuana-based drugs.
Scientists believe that the drug could eventually...
